Zobrazeno 1 - 10
of 348
pro vyhledávání: '"Roosendaal, J"'
Autor:
Roosendaal J; Department of Toxicology, Netherlands Forensic Institute, Laan van Ypenburg 6, The Hague, 2497 GB, The Netherlands., Oosting R; Department of Toxicology, Netherlands Forensic Institute, Laan van Ypenburg 6, The Hague, 2497 GB, The Netherlands., Kloos DP; Department of Toxicology, Netherlands Forensic Institute, Laan van Ypenburg 6, The Hague, 2497 GB, The Netherlands., de Boer HH; Department of Forensic Medicine, Victorian Institute of Forensic Medicine, Monash University, 65 Kavanagh St, Southbank, VIC 3006, Australia., van den Berg JDJ; Department of Illicit Drugs, Netherlands Forensic Institute, Laan van Ypenburg 6, The Hague, 2497 GB, The Netherlands., Oldenhof S; Department of Illicit Drugs, Netherlands Forensic Institute, Laan van Ypenburg 6, The Hague, 2497 GB, The Netherlands., Bosman IJ; Department of Toxicology, Netherlands Forensic Institute, Laan van Ypenburg 6, The Hague, 2497 GB, The Netherlands.
Publikováno v:
Journal of analytical toxicology [J Anal Toxicol] 2023 Jul 22; Vol. 47 (6), pp. 541-546.
Autor:
Roosendaal, J, Venekamp, N, Lucas, L, Rosing, H, Beijnen, J H, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Die Pharmazie, 75(4), 136. Govi-Verlag Pharmazeutischer Verlag GmbH
Here we describe the development and validation of an LC-MS/MS method for the quantification of imatinib and imatinib-d8 in plasma for the support of a clinical absolute bioavailability microdosing trial. The focus lies on the technical aspects to an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::608e9d6a0e262aeaa953bf620b2b808e
https://dspace.library.uu.nl/handle/1874/411152
https://dspace.library.uu.nl/handle/1874/411152
Autor:
Janssen JM; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. ju.janssen@nki.nl., Jacobs BAW; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Roosendaal J; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Derissen EJB; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam UMC, Amsterdam, The Netherlands., Marchetti S; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Dorlo TPC; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Publikováno v:
The AAPS journal [AAPS J] 2021 Jan 08; Vol. 23 (1), pp. 23. Date of Electronic Publication: 2021 Jan 08.
Autor:
Sow, Aïssatou Aïcha1 (AUTHOR), Jamadagni, Priyanka1 (AUTHOR), Scaturro, Pietro2 (AUTHOR), Patten, Shunmoogum A.1,3,4 (AUTHOR) kessen.patten@inrs.ca, Chatel-Chaix, Laurent1,3,4,5 (AUTHOR) laurent.chatel-chaix@inrs.ca
Publikováno v:
PLoS Pathogens. 12/2/2024, Vol. 20 Issue 12, p1-33. 33p.
Autor:
Menéndez-Quintanal, Luis Manuel1 (AUTHOR) francisco.hernandez@justicia.es, Matey, Jose Manuel2,3 (AUTHOR) gemma.montalvo@uah.es, del Fresno González, Violeta2,3 (AUTHOR) carmen.gruiz@uah.es, Bravo Serrano, Begoña2,3 (AUTHOR) begona.bravo@justicia.es, Hernández-Díaz, Francisco Javier1 (AUTHOR), Zapata, Félix4 (AUTHOR) felix.zapata@um.es, Montalvo, Gemma3,5 (AUTHOR), García-Ruiz, Carmen3,5 (AUTHOR)
Publikováno v:
Psychoactives. Dec2024, Vol. 3 Issue 4, p525-610. 86p.
Autor:
Colita, Cezar-Ivan1 (AUTHOR) cezar.ivan23@gmail.com, Hermann, Dirk M.2,3 (AUTHOR) dirk.hermann@uk-essen.de, Filfan, Madalina3 (AUTHOR), Colita, Daniela1 (AUTHOR) danielacolita@gmail.com, Doepnner, Thorsten R.4 (AUTHOR) thorsten.doeppner@neuro.med.uni-giessen.de, Tica, Oana5 (AUTHOR) oanasorinatica@gmail.com, Glavan, Daniela3 (AUTHOR) danaglavan@gmail.com, Popa-Wagner, Aurel1,2 (AUTHOR) danaglavan@gmail.com
Publikováno v:
Clocks & Sleep. Dec2024, Vol. 6 Issue 4, p635-655. 21p.
Autor:
Roosendaal J; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Heidebrecht T; Department of Biochemistry, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands; Oncode Institute, the Netherlands., Rosing H; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Perrakis A; Department of Biochemistry, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands; Oncode Institute, the Netherlands., Beijnen JH; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Division of Pharmacoepidemiology and Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Division of Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, the Netherlands. Electronic address: j.roosendaal@nki.nl.
Publikováno v:
Analytical biochemistry [Anal Biochem] 2020 Dec 01; Vol. 610, pp. 113930. Date of Electronic Publication: 2020 Aug 29.
Autor:
Roosendaal J; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. j.roosendaal@nki.nl., Groenland SL; Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Rosing H; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Lucas L; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Venekamp N; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Nuijen B; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center, Utrecht University, Utrecht, The Netherlands., Beijnen JH; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Steeghs N; Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Publikováno v:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2020 Aug; Vol. 76 (8), pp. 1075-1082. Date of Electronic Publication: 2020 May 19.
Autor:
Roosendaal J; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. j.roosendaal@nki.nl.; Division of Pharmacoepidemiology and Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. j.roosendaal@nki.nl., Rosing H; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Lucas L; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Gebretensae A; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Dongen MG; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Beijnen JH; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Division of Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Oganesian A; Astex Pharmaceuticals, Inc., Pleasanton, California, USA.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2020 Aug; Vol. 38 (4), pp. 1085-1095. Date of Electronic Publication: 2019 Oct 11.
Autor:
Roosendaal J; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Rosing H; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Beijnen JH; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Division of Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2020 Jul; Vol. 9 (5), pp. 552-559. Date of Electronic Publication: 2020 Jun 22.